CDKN2A and meningioma: In a follow-up study, the same authors reported that meningothelial proliferation and meningioma frequency increased, without variations in the tumor grade, in mice nullizygous for the tumor suppressor p16 (Ink4a), revealing a synergy between NF2 and p16 inactivation in meningioma development [181].